Loading…

SOX18 Expression in Non-melanoma Skin Cancer

SRY-related HMG box protein 18 (SOX18) is a transcription factor involved in a range of physiological processes, including differentiation of endothelial cells during new vessel formation. Numerous studies are being conducted to determine its role in carcinogenesis. Thirty-five cases of squamous cel...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2016-05, Vol.36 (5), p.2379
Main Authors: Ornat, Maciej, Kobierzycki, Christopher, Grzegrzolka, Jedrzej, Pula, Bartosz, Zamirska, Aleksandra, Bieniek, Andrzej, Szepietowski, Jacek C, Dziegiel, Piotr, Okolow, Marzenna Podhorska
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 5
container_start_page 2379
container_title Anticancer research
container_volume 36
creator Ornat, Maciej
Kobierzycki, Christopher
Grzegrzolka, Jedrzej
Pula, Bartosz
Zamirska, Aleksandra
Bieniek, Andrzej
Szepietowski, Jacek C
Dziegiel, Piotr
Okolow, Marzenna Podhorska
description SRY-related HMG box protein 18 (SOX18) is a transcription factor involved in a range of physiological processes, including differentiation of endothelial cells during new vessel formation. Numerous studies are being conducted to determine its role in carcinogenesis. Thirty-five cases of squamous cell carcinoma (SCC), 61 cases of basal cell carcinoma (BCC), 15 cases of actinic keratosis (AK) and 15 normal skin (NS) cases were examined in the study. Expression of SOX18 was investigated with immunohistochemistry and light optic microscopy. The obtained results were subjected to statistical analysis including available clinicopathological data. Nuclear expression of SOX18 was shown in vascular endothelial cells, basal layer cells of NS epidermis, as well as in AK, BCC and SCC cancer cells. Expression of SOX18 in SCC, BCC and AK cells was significantly higher than in NS (p
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_27127146</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>27127146</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-36887359da8ecefd76a1782199b0c88587844402f3173881654c0219747675d13</originalsourceid><addsrcrecordid>eNo1jt1qwkAUhBehqFVfQfIALuzJ_pyzlxK0LYheqOCdrMkGomYTsgrt2zfQCgMD38DHDNgY0AJHLcWIvcd4FcIYS3LIRilCH2XGbLHfnYCS1Xfb-RirJiRVSLZN4LW_u9DULtnfepK5kPtuyt5Kd49-9t8TdlyvDtkn3-w-vrLlhrcpwINLQ4RS28KRz31ZoHGAlIK1F5ETaUJSSom0lICSCIxWuehnVGhQFyAnbP7nbZ-X2hfntqtq1_2cX7flLzFKOb4</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>SOX18 Expression in Non-melanoma Skin Cancer</title><source>EZB Electronic Journals Library</source><creator>Ornat, Maciej ; Kobierzycki, Christopher ; Grzegrzolka, Jedrzej ; Pula, Bartosz ; Zamirska, Aleksandra ; Bieniek, Andrzej ; Szepietowski, Jacek C ; Dziegiel, Piotr ; Okolow, Marzenna Podhorska</creator><creatorcontrib>Ornat, Maciej ; Kobierzycki, Christopher ; Grzegrzolka, Jedrzej ; Pula, Bartosz ; Zamirska, Aleksandra ; Bieniek, Andrzej ; Szepietowski, Jacek C ; Dziegiel, Piotr ; Okolow, Marzenna Podhorska</creatorcontrib><description>SRY-related HMG box protein 18 (SOX18) is a transcription factor involved in a range of physiological processes, including differentiation of endothelial cells during new vessel formation. Numerous studies are being conducted to determine its role in carcinogenesis. Thirty-five cases of squamous cell carcinoma (SCC), 61 cases of basal cell carcinoma (BCC), 15 cases of actinic keratosis (AK) and 15 normal skin (NS) cases were examined in the study. Expression of SOX18 was investigated with immunohistochemistry and light optic microscopy. The obtained results were subjected to statistical analysis including available clinicopathological data. Nuclear expression of SOX18 was shown in vascular endothelial cells, basal layer cells of NS epidermis, as well as in AK, BCC and SCC cancer cells. Expression of SOX18 in SCC, BCC and AK cells was significantly higher than in NS (p&lt;0.01, p&lt;0.001 and p&lt;0.01, respectively). Additionally, higher expression of SOX18 in BCC than in SCC cells (p&lt;0.001) was observed. SOX18 may play a role in the development of BCC and SCC. Further studies with the use of additional markers tested at the mRNA and protein level are necessary for better explanation of SOX18 function in cancer transformation.</description><identifier>EISSN: 1791-7530</identifier><identifier>PMID: 27127146</identifier><language>eng</language><publisher>Greece</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Carcinoma, Basal Cell - metabolism ; Carcinoma, Squamous Cell - metabolism ; Case-Control Studies ; Female ; Humans ; Keratosis, Actinic - metabolism ; Male ; Middle Aged ; Skin Neoplasms - metabolism ; SOXF Transcription Factors - metabolism</subject><ispartof>Anticancer research, 2016-05, Vol.36 (5), p.2379</ispartof><rights>Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27127146$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ornat, Maciej</creatorcontrib><creatorcontrib>Kobierzycki, Christopher</creatorcontrib><creatorcontrib>Grzegrzolka, Jedrzej</creatorcontrib><creatorcontrib>Pula, Bartosz</creatorcontrib><creatorcontrib>Zamirska, Aleksandra</creatorcontrib><creatorcontrib>Bieniek, Andrzej</creatorcontrib><creatorcontrib>Szepietowski, Jacek C</creatorcontrib><creatorcontrib>Dziegiel, Piotr</creatorcontrib><creatorcontrib>Okolow, Marzenna Podhorska</creatorcontrib><title>SOX18 Expression in Non-melanoma Skin Cancer</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>SRY-related HMG box protein 18 (SOX18) is a transcription factor involved in a range of physiological processes, including differentiation of endothelial cells during new vessel formation. Numerous studies are being conducted to determine its role in carcinogenesis. Thirty-five cases of squamous cell carcinoma (SCC), 61 cases of basal cell carcinoma (BCC), 15 cases of actinic keratosis (AK) and 15 normal skin (NS) cases were examined in the study. Expression of SOX18 was investigated with immunohistochemistry and light optic microscopy. The obtained results were subjected to statistical analysis including available clinicopathological data. Nuclear expression of SOX18 was shown in vascular endothelial cells, basal layer cells of NS epidermis, as well as in AK, BCC and SCC cancer cells. Expression of SOX18 in SCC, BCC and AK cells was significantly higher than in NS (p&lt;0.01, p&lt;0.001 and p&lt;0.01, respectively). Additionally, higher expression of SOX18 in BCC than in SCC cells (p&lt;0.001) was observed. SOX18 may play a role in the development of BCC and SCC. Further studies with the use of additional markers tested at the mRNA and protein level are necessary for better explanation of SOX18 function in cancer transformation.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Carcinoma, Basal Cell - metabolism</subject><subject>Carcinoma, Squamous Cell - metabolism</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Keratosis, Actinic - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Skin Neoplasms - metabolism</subject><subject>SOXF Transcription Factors - metabolism</subject><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNo1jt1qwkAUhBehqFVfQfIALuzJ_pyzlxK0LYheqOCdrMkGomYTsgrt2zfQCgMD38DHDNgY0AJHLcWIvcd4FcIYS3LIRilCH2XGbLHfnYCS1Xfb-RirJiRVSLZN4LW_u9DULtnfepK5kPtuyt5Kd49-9t8TdlyvDtkn3-w-vrLlhrcpwINLQ4RS28KRz31ZoHGAlIK1F5ETaUJSSom0lICSCIxWuehnVGhQFyAnbP7nbZ-X2hfntqtq1_2cX7flLzFKOb4</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Ornat, Maciej</creator><creator>Kobierzycki, Christopher</creator><creator>Grzegrzolka, Jedrzej</creator><creator>Pula, Bartosz</creator><creator>Zamirska, Aleksandra</creator><creator>Bieniek, Andrzej</creator><creator>Szepietowski, Jacek C</creator><creator>Dziegiel, Piotr</creator><creator>Okolow, Marzenna Podhorska</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20160501</creationdate><title>SOX18 Expression in Non-melanoma Skin Cancer</title><author>Ornat, Maciej ; Kobierzycki, Christopher ; Grzegrzolka, Jedrzej ; Pula, Bartosz ; Zamirska, Aleksandra ; Bieniek, Andrzej ; Szepietowski, Jacek C ; Dziegiel, Piotr ; Okolow, Marzenna Podhorska</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-36887359da8ecefd76a1782199b0c88587844402f3173881654c0219747675d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Carcinoma, Basal Cell - metabolism</topic><topic>Carcinoma, Squamous Cell - metabolism</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Keratosis, Actinic - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Skin Neoplasms - metabolism</topic><topic>SOXF Transcription Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ornat, Maciej</creatorcontrib><creatorcontrib>Kobierzycki, Christopher</creatorcontrib><creatorcontrib>Grzegrzolka, Jedrzej</creatorcontrib><creatorcontrib>Pula, Bartosz</creatorcontrib><creatorcontrib>Zamirska, Aleksandra</creatorcontrib><creatorcontrib>Bieniek, Andrzej</creatorcontrib><creatorcontrib>Szepietowski, Jacek C</creatorcontrib><creatorcontrib>Dziegiel, Piotr</creatorcontrib><creatorcontrib>Okolow, Marzenna Podhorska</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ornat, Maciej</au><au>Kobierzycki, Christopher</au><au>Grzegrzolka, Jedrzej</au><au>Pula, Bartosz</au><au>Zamirska, Aleksandra</au><au>Bieniek, Andrzej</au><au>Szepietowski, Jacek C</au><au>Dziegiel, Piotr</au><au>Okolow, Marzenna Podhorska</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SOX18 Expression in Non-melanoma Skin Cancer</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>36</volume><issue>5</issue><spage>2379</spage><pages>2379-</pages><eissn>1791-7530</eissn><abstract>SRY-related HMG box protein 18 (SOX18) is a transcription factor involved in a range of physiological processes, including differentiation of endothelial cells during new vessel formation. Numerous studies are being conducted to determine its role in carcinogenesis. Thirty-five cases of squamous cell carcinoma (SCC), 61 cases of basal cell carcinoma (BCC), 15 cases of actinic keratosis (AK) and 15 normal skin (NS) cases were examined in the study. Expression of SOX18 was investigated with immunohistochemistry and light optic microscopy. The obtained results were subjected to statistical analysis including available clinicopathological data. Nuclear expression of SOX18 was shown in vascular endothelial cells, basal layer cells of NS epidermis, as well as in AK, BCC and SCC cancer cells. Expression of SOX18 in SCC, BCC and AK cells was significantly higher than in NS (p&lt;0.01, p&lt;0.001 and p&lt;0.01, respectively). Additionally, higher expression of SOX18 in BCC than in SCC cells (p&lt;0.001) was observed. SOX18 may play a role in the development of BCC and SCC. Further studies with the use of additional markers tested at the mRNA and protein level are necessary for better explanation of SOX18 function in cancer transformation.</abstract><cop>Greece</cop><pmid>27127146</pmid></addata></record>
fulltext fulltext
identifier EISSN: 1791-7530
ispartof Anticancer research, 2016-05, Vol.36 (5), p.2379
issn 1791-7530
language eng
recordid cdi_pubmed_primary_27127146
source EZB Electronic Journals Library
subjects Adult
Aged
Aged, 80 and over
Carcinoma, Basal Cell - metabolism
Carcinoma, Squamous Cell - metabolism
Case-Control Studies
Female
Humans
Keratosis, Actinic - metabolism
Male
Middle Aged
Skin Neoplasms - metabolism
SOXF Transcription Factors - metabolism
title SOX18 Expression in Non-melanoma Skin Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A26%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SOX18%20Expression%20in%20Non-melanoma%20Skin%20Cancer&rft.jtitle=Anticancer%20research&rft.au=Ornat,%20Maciej&rft.date=2016-05-01&rft.volume=36&rft.issue=5&rft.spage=2379&rft.pages=2379-&rft.eissn=1791-7530&rft_id=info:doi/&rft_dat=%3Cpubmed%3E27127146%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p211t-36887359da8ecefd76a1782199b0c88587844402f3173881654c0219747675d13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/27127146&rfr_iscdi=true